临近年终,跨国药企并购潮升温,罗氏、辉瑞、默沙东等接连落子,本周强生又有新动作。11 月 17 日,强生宣布已签署最终协议,将以 30.5 亿美元现金收购 Halda Therapeutics,这成为近期竞争激烈的生物技术公司争夺战中的最新一笔交易。Halda 是一家临床阶段的生物技术公司,拥有专有的 RIPTAC™(Regulated Induced Proximity TArgeting ...
Source Link临近年终,跨国药企并购潮升温,罗氏、辉瑞、默沙东等接连落子,本周强生又有新动作。11 月 17 日,强生宣布已签署最终协议,将以 30.5 亿美元现金收购 Halda Therapeutics,这成为近期竞争激烈的生物技术公司争夺战中的最新一笔交易。Halda 是一家临床阶段的生物技术公司,拥有专有的 RIPTAC™(Regulated Induced Proximity TArgeting ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.